Terminated PHASE4 INTERVENTIONAL 1-arm NCT01513031

Determination of Rates and Reasons for Non-Adherence to Anti-Arrhythmic Therapy for Atrial Fibrillation

Pilot Project to Determine Rates and Reasons for Non-Adherence in Patients Receiving Chronic Oral Antiarrhythmic Therapy for Atrial Fibrillation in the State of Nebraska

Sponsor: Creighton University

Conditions Atrial Fibrillation Medication Adherence

Interventions Education and telephone follow-up

Updated 5 times since 2017 Last updated: Jun 28, 2012 Started: Jan 31, 2012 Primary completion: Jun 30, 2012 Completion: Jun 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Low enrollment

Other terminated trials from Creighton University

See all terminations from Creighton University

Other Atrial Fibrillation trials with similar outcome

Browse all Atrial Fibrillation trials

Listed as NCT01513031, this PHASE4 trial focuses on Atrial Fibrillation and Medication Adherence and remains terminated or withdrawn. Sponsored by Creighton University, it has been updated 5 times since 2012, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Creighton University
Sanofi

Data source: Creighton University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lincoln, United States
• Omaha, United States